Briefs

LeadScope(R) Inc. today announced that it is collaborating with the
FDA under a Material Transfer Agreement (MTA). The agreement allows
the FDA to use LeadScope Enterprise(TM) (both server and desktop
version) for data mining and decision support. The agreement is with
the Center for Drug Evaluation and Research (CDER) and the Center for
Food Safety and Applied Nutrition (CFSAN).

LeadScope Enterprise is chemically intelligent decision-support
software that rapidly identifies correlations between chemical
structural features and any biological end-point, such as toxicity. It
has been used extensively to identify toxic structural alerts.

Proprietary toxicity data can be supplemented with data from the
LeadScope ToxScope(TM) database, currently containing approximately
150,000 compounds with toxicity information. These toxic alerts can
then be used with LeadScope Enterprise to share this knowledge
throughout an organization, helping scientists avoid potential toxic
compounds earlier in the drug development process.

For additional information, see www.leadscope.com